| Authors: |
Hendley AM; Diabetes Center, University of California, San Francisco, San Francisco, United States.; Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, San Francisco, United States., Rao AA; CoLabs, University of California, San Francisco, San Francisco, United States.; Bakar ImmunoX Initiative, University of California, San Francisco, San Francisco, United States., Leonhardt L; Diabetes Center, University of California, San Francisco, San Francisco, United States., Ashe S; Diabetes Center, University of California, San Francisco, San Francisco, United States., Smith JA; Diabetes Center, University of California, San Francisco, San Francisco, United States., Giacometti S; Diabetes Center, University of California, San Francisco, San Francisco, United States., Peng XL; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, United States., Jiang H; Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United States., Berrios DI; Diabetes Center, University of California, San Francisco, San Francisco, United States., Pawlak M; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, United States., Li LY; Diabetes Center, University of California, San Francisco, San Francisco, United States., Lee J; Diabetes Center, University of California, San Francisco, San Francisco, United States., Collisson EA; Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United States., Anderson MS; Diabetes Center, University of California, San Francisco, San Francisco, United States., Fragiadakis GK; CoLabs, University of California, San Francisco, San Francisco, United States.; Bakar ImmunoX Initiative, University of California, San Francisco, San Francisco, United States.; Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, United States., Yeh JJ; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, United States., Ye CJ; Parker Institute for Cancer Immunotherapy, San Francisco, United States., Kim GE; Department of Pathology, University of California, San Francisco, San Francisco, United States., Weaver VM; Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, San Francisco, United States., Hebrok M; Diabetes Center, University of California, San Francisco, San Francisco, United States. |
